What Does ‘Breakthrough’ Mean to Docs and Consumers? It’s Not the FDA Definition – FiercePharma

Read article - Quotes Steve Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, and co-author of a recent study which found that when the FDA designates a drug as a "breakthrough" therapy, 77 percent of physicians think it means there is "high-quality evidence" that the drug is more effective than current treatments.